Siwei (Shanghai) Biotechnology Co., Ltd.


As a biotechnology startup based in China, Stemirna understands the importance of collaboration and partnering. As we try to make progress in our own research and development, we constantly seek partnerships with organizations in every link of the value chain so that we as an industry can bring new medicines and treatments to patients faster.

Partnerships in Clinical Trials

We have three ongoing investigator-initiated trials with three top-tier hospitals in China to study the safety, tolerability and efficacy of mRNA-based personalized cancer vaccine.

  • Shanghai East Hospital of Tongji University

  • Shanghai Changhai Hospital

  • First Affiliated Hospital of Zhengzhou University

Partnerships in Pipeline Development

As an effort to expand our pipeline, we have established partnerships with both academia and industry.

  • Shanghai Ruijin Hospital

About Us
- Our Story
- News Updates
- Contact Us
- mRNA Synthesis Platform
- LPP Delivery Platform
- GMP Manufacturing
- Therapeutic Areas
- Development Candidates
- Clinical Trials
- Investors
Join Us
- Opportunities